These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat. Ashida SI; Abiko Y Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522 [TBL] [Abstract][Full Text] [Related]
3. Effects of halothane on the cyclic 3',5'-adenosine monophosphate enzyme system in human platelets. Walter F; Vulliemoz Y; Verosky Y; Triner L Anesth Analg; 1980 Nov; 59(11):856-61. PubMed ID: 6252800 [TBL] [Abstract][Full Text] [Related]
4. [Biochemical mechanism of blood platelet release reaction, aggregation and adhesiveness]. Hidaka H; Ikukawa S Nihon Rinsho; 1978 Dec; 36(12):3798-804. PubMed ID: 219272 [No Abstract] [Full Text] [Related]
5. Cyclic 3',5'-adenosine monophosphate in human blood platelets. 3. The role of cyclic AMP in platelet aggregation. Salzman EW; Rubino EB; Sims RV Ser Haematol; 1970; 3(4):100-13. PubMed ID: 4329913 [No Abstract] [Full Text] [Related]
6. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation. Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792 [TBL] [Abstract][Full Text] [Related]
7. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins. Alvarez R; Taylor A; Fazzari JJ; Jacobs JR Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089 [No Abstract] [Full Text] [Related]
8. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148 [TBL] [Abstract][Full Text] [Related]
10. [Mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 3. Significance of prostaglandins and cAMP for aggregation inhibiting effect and other effects of sulfonylurea compounds]. Scholz VC; Hoder A; Losert W Arzneimittelforschung; 1975 Mar; 25(3):347-61. PubMed ID: 239727 [No Abstract] [Full Text] [Related]
11. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Maurice DH; Haslam RJ Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060 [TBL] [Abstract][Full Text] [Related]
12. [Change in the adenylate cyclase activity of the lymphocytes and thrombocytes in irradiated sheep]. Shevchenko AS Radiobiologiia; 1990; 30(3):308-11. PubMed ID: 2164696 [TBL] [Abstract][Full Text] [Related]
13. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications. Hidaka H; Endo T Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253 [No Abstract] [Full Text] [Related]
14. Increased platelet adenylate cyclase activity ion diabetic patients with microangiography. Janka HU; Standl E; Mehnert H Horm Metab Res Suppl; 1981; 11():26-9. PubMed ID: 6172351 [TBL] [Abstract][Full Text] [Related]
15. [Reactions of platelets to various stimuli]. Kobayashi B Rinsho Byori; 1979; Suppl 40():13-29. PubMed ID: 233104 [No Abstract] [Full Text] [Related]
16. Regulation of phospholipase activity in platelets. Lapetina EG; Schmitges CJ; Chandrabose K; Cuatrecasas P Adv Prostaglandin Thromboxane Res; 1978; 3():127-35. PubMed ID: 207172 [No Abstract] [Full Text] [Related]